318 related articles for article (PubMed ID: 9754818)
1. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.
Eriksson KF; Lindgärde F
Diabetologia; 1998 Sep; 41(9):1010-6. PubMed ID: 9754818
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
[TBL] [Abstract][Full Text] [Related]
3. Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention.
Venojärvi M; Puhke R; Hämäläinen H; Marniemi J; Rastas M; Rusko H; Nuutila P; Hänninen O; Aunola S
Diabetes Obes Metab; 2005 Nov; 7(6):745-54. PubMed ID: 16219019
[TBL] [Abstract][Full Text] [Related]
4. Review of previous impaired glucose tolerance intervention studies.
Melander A
Diabet Med; 1996; 13(3 Suppl 2):S20-2. PubMed ID: 8689857
[TBL] [Abstract][Full Text] [Related]
5. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
Mohan V; Shanthirani CS; Deepa R
J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance.
Oldroyd JC; Unwin NC; White M; Mathers JC; Alberti KG
Diabetes Res Clin Pract; 2006 May; 72(2):117-27. PubMed ID: 16297488
[TBL] [Abstract][Full Text] [Related]
8. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
[TBL] [Abstract][Full Text] [Related]
10. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
Alvarsson M; Hilding A; Ostenson CG
Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
[TBL] [Abstract][Full Text] [Related]
11. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
12. Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance.
Fritz T; Caidahl K; Krook A; Lundström P; Mashili F; Osler M; Szekeres FL; Östenson CG; Wändell P; Zierath JR
Diabetes Metab Res Rev; 2013 Jan; 29(1):25-32. PubMed ID: 22887834
[TBL] [Abstract][Full Text] [Related]
13. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study.
Roumen C; Corpeleijn E; Feskens EJ; Mensink M; Saris WH; Blaak EE
Diabet Med; 2008 May; 25(5):597-605. PubMed ID: 18445174
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec.
Delisle HF; Ekoé JM
CMAJ; 1993 Jan; 148(1):41-7. PubMed ID: 8439889
[TBL] [Abstract][Full Text] [Related]
15. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
[TBL] [Abstract][Full Text] [Related]
16. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.
Hu G; Lindström J; Valle TT; Eriksson JG; Jousilahti P; Silventoinen K; Qiao Q; Tuomilehto J
Arch Intern Med; 2004 Apr; 164(8):892-6. PubMed ID: 15111376
[TBL] [Abstract][Full Text] [Related]
17. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
[TBL] [Abstract][Full Text] [Related]
18. Long-term (1- and 2-year) effects of lifestyle intervention in type 2 diabetes relatives.
Brekke HK; Jansson PA; Lenner RA
Diabetes Res Clin Pract; 2005 Dec; 70(3):225-34. PubMed ID: 15885845
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.
Suadicani P; Hein HO; von Eyben FE; Gyntelberg F
Metab Syndr Relat Disord; 2009 Apr; 7(2):97-104. PubMed ID: 19032035
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
